We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAY:NYSEPaymentus Holdings, Inc. Analysis

Data as of 2026-04-23 - not real-time

$27.11

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Paymentus Holdings (PAY) is trading below its long‑term moving average while staying above short‑term averages, indicating a neutral‑to‑bullish technical stance. The MACD histogram is positive and the RSI sits in the mid‑range, suggesting limited downside momentum and room for upside. Fundamentally, the company delivers robust revenue growth and a solid cash position, yet its valuation multiples are elevated relative to peers, though a discounted cash‑flow model points to a meaningful upside potential. Recent material news includes the upcoming first‑quarter earnings release, a sizable RSU grant to the CEO, and the departure of the general counsel, all of which could add short‑term volatility.
Overall, the blend of positive technical signals, strong growth fundamentals, and an implied valuation gap supports a cautiously optimistic outlook, with the primary catalysts being earnings momentum and continued adoption of its cloud‑based payment platform.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD and neutral RSI indicating limited downside
  • Upcoming earnings report could unlock upside
  • Current price positioned between short‑term support and long‑term resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained double‑digit revenue growth
  • Strong cash generation and low leverage
  • Analyst consensus of buy and implied upside from valuation models

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term secular shift toward digital and cloud‑based payment solutions
  • Stable operating margins with potential for improvement
  • Undervalued relative to discounted cash‑flow fair value despite high PE

Key Metrics & Analysis

Financial Health

Revenue Growth28.10%
Profit Margin5.59%
P/E Ratio52.1
ROE12.80%
ROA7.59%
Debt/Equity1.22
P/B Ratio6.1
Op. Cash Flow$162.1M
Free Cash Flow$112.8M
Industry P/E37.0

Technical Analysis

TrendNeutral
RSI54.7
Support$24.07
Resistance$29.77
MA 20$26.15
MA 50$25.32
MA 200$30.37
MACDBullish
VolumeStable
Fear & Greed Index86.34

Valuation

Fair Value$35.78
Target Price$32.29
Upside/Downside19.11%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.00
Volatility41.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.